Home › Cancer (all types) › NCT00505245
New Assessment System in Measuring Symptom Distress in Cancer Patients
Measuring the Symptom Distress of Cancer Patients: Development of a New Assessment System
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * NORMAL SAMPLES: Community dwelling adults 18 years of age or older * PATIENT SAMPLES: Inpatients and outpatients 18 years of age or older, being followed at UT MD Anderson * EXPERT PANEL PROFESSIONAL PARTICIPANTS: Physician or other healthcare provider with at least 5 years of experience caring for patients with the disease and/or treatment of interest, at least one publication in the last 5 years dealing with the disease and/or treatment of interest (physician only), ability to speak and read English, consent to participate * EXPERT PANEL FAMILY CAREGIVERS PARTICIPANTS: Identification as a family caregiver by patient enrolled as expert panel participant with the disease and/or treatment of interest, 18 years of age or older, ability to speak and read English, consent to participate * EXPERT PANEL PATIENT PARTICIPANTS: Patient with identified family caregiver participating on Expert Panel, willingness to receive packet for expert panel participation Exclusion Criteria: * EXPERT PANEL PATIENT PARTICIPANTS: Patient with identified family caregiver participating on expert panel, willingness to receive packet for expert panel participation
About the study
This trial studies how well a new assessment system (MDASI or other MD Anderson-developed PRO instrument) works in measuring symptoms and the impact on quality of life in cancer patients. Development of a new assessment system may provide more information about the common symptoms that may occur in patients due to cancer and its treatment and how the symptoms impact quality of life.
What is being tested
- Interview (other)
- Quality-of-Life Assessment (other)
- Questionnaire Administration (other)
Sponsor: M.D. Anderson Cancer Center · Participants: 6,500 · Started: Apr 13, 1999
Contact the study team
- Xin Shelley Wang · Phone: 713-745-3504
Official record on ClinicalTrials.gov — NCT00505245
Locations in the U.S.
| Texas | M D Anderson Cancer Center, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.